nanosymposium - Society for Neuroscience

4:00 Z11 460.16 Role of sodium/hydrogen exchanger
isoform 1 in microglial activation and proinflammatory
responses in ischemic brains. Y. SHI*; V. CHANANA; J. J.
WATTERS; P. FERRAZZANO; D. SUN. Univ. of Wisconsin-
Madison, Univ. of Wisconsin-Madison, Univ. of Pittsburgh,
Univ. of Wisconsin-Madison, Univ. of Wisconsin-Madison,
Univ. of Wisconsin-Madison.
1:00 Z12 460.17 Spatiotemporal localization of CD200 and
its receptor in the developing C57BL/6 mice brain following
Hypoxia/Ischemia injury. K. SHRIVASTAVA*; G. LLOVERA;
L. ACARIN. Inst. of Neurosciences. Univ. Autonoma
Barcelona.
2:00 Z13 460.18 • Effects of a semi-purified soy protein
diet on skilled ladder rung walking and neuroinflammatory
markers after stroke in rats. J. L. CHEATWOOD*; A. N.
KNAPP; A. R. SIERMAN; J. AN; D. N. BUTTEIGER; J. R.
KÖPPEN; D. G. WALLACE; W. J. BANZ. SIU Sch. Med.,
Solae, LLC, Northern Illinois Univ., Southern Illinois Univ.
3:00 Z14 460.19 NG2-positive cells and NG2 extracellular
protein constitute demarcation of focal cerebral infarction
in rats. H. L. CLAUS; M. WALBERER; S. M. MUESKEN; B.
EMIG; M. A. RUEGER; G. R. FINK; M. SCHROETER*. Dept.
of Neurology, Univ. Hosp. Cologne, Max-Planck-Institute for
Neurolog. Res., Res. Ctr. Juelich.
POSTER
461. Demyelinating Disorders: Molecular and Cellular
Mechanisms I
Theme C: Disorders of the Nervous System
Mon. 1:00 PM – Walter E. Washington Convention
Center, Hall A-C
1:00 Z15 461.01 Aberrant activation of mTOR promotes
Schwann cell dedifferentiation. S. HAGERTY*; P. MAUREL;
K. NAVE; J. SALZER. New York Univ. Langone Med. Ctr.,
Rutgers, Max Planck Inst. of Exptl. Med.
2:00 Z16 461.02 • Inhibition of Nogo signaling potentiates
SVZ cells mobilization in response to mouse optic chiasm
demyelination. F. POURABDOLHOSSEIN*; M. JAVAN;
B. DEMENEIX; S. MIRNAJAFIZADEH; S. MOZAFARI; S.
DEHGHAN; A. BARON VAN-EVERCOOREN. Section 5.031,
5th Floor, ICM Building, 47 Bd De L’Hôpital, Tarbiat Modares
Univ., Muséum Natl. d’Histoire Naturelle.
3:00 Z17 461.03 Cyclooxygenase-2 and prostanoids are
associated with excitotoxic death of oligodendrocytes in
culture. N. G. CARLSON*; M. A. ROJAS; J. REDD; B. WOOD;
M. JENSEN; J. W. ROSE. Univ. Utah, VA Salt Lake Hlth. Care
Syst., Univ. Utah, VA Salt Lake City Hlth. Care Syst.
4:00 Z18 461.04 Primary oligodendrocyte death does
not elicit anti-CNS immunity. G. LOCATELLI*; T. BUCH;
S. WOERTGE; B. INGOLD-HEPPNER; F. FROMMER;
B. SOBOTTKA; C. BUEHLMANN; I. BECHMANN; F.
HEPPNER; A. WAISMAN; B. BECHER. Univ. Zuerich, Tech.
Univ. Muenich, Universitätsmedizin der Johanne Gutenberg
Univ., Charité –Universitätsmedizin Berlin, Univ. of Leipzig.
1:00 Z19 461.05 • Thymosin beta 4 (Tβ4) mediates
oligodendrocyte differentiation by activation of the p38 MAPK
signaling pathway. M. SANTRA; D. MORRIS*; S. SANTRA;
Z. ZHANG; M. CHOPP. Henry Ford Hlth. Systems, Henry
Ford Hlth. Systems.
• Indicated a real or perceived conflict of interest, see page 162 for details.
� Indicates a high school or undergraduate student presenter.
2:00 Z20 461.06 Kainic acid receptors in experimental
autoimmune encephalomyelitis. M. IMBESI*; A.
CONTRACTOR; G. T. SWANSON. Northwestern Univ.,
Northwestern Univ.
3:00 Z21 461.07 Alterations in Olig1 and MBP in Vanishing
White Matter disease in protein and mRNA level. A.
TAKANOHASHI*; A. VANDERVER. Children’s Natl. Med. Ctr.
4:00 Z22 461.08 The anti-aging protein Klotho enhances
oligodendrocyte maturation and myelination. C. R.
ABRAHAM*; J. A. SLOANE; N. AYTAN; L. GIANNARIS; G.
KING; M. KURO-O; C. CHEN. Boston Univ. Med. Sch., Beth
Istrael Deaconess Med. Ctr., Boston VA Med. Ctr., Boston
Univ. Sch. Med., Univ. Texas Southwestern Med. Ctr.,
Boston Univer Sch. Med.
1:00 Z23 461.09 Delivery of BMP4 and Noggin to
the demyelinated mouse brain modulates numbers of
oligodendrocytes and astrocytes during recovery. J. SABO;
T. AUMANN; D. MERLO; T. KILPATRICK; H. S. CATE*. Ctr.
For Neuroscience, Univ. of Melbourne, Florey Neurosci. Inst.
2:00 Z24 461.10 Ex vivo spinal cord slice culture model of
neuromyelitis optica for study of pathogenic mechanisms. H.
ZHANG*; J. L. BENNETT; A. S. VERKMAN. UCSF, Univ. of
Colorado Denver Sch. of Med.
3:00 Z25 461.11 Role of Slit1 and Robo2 in an animal
model of demyelination. G. SPIGONI; C. DEBOUX; B.
NAIT-OUMESMAR*; A. CHEDOTAL; A. BARON VAN
EVERCOOREN. Cr-Icm, Inserm-Univ. Pierre & Marie Curie,
Umr-S975, CNRS UMR 7225, Dept. de Développement,
Inst. de la Vision, Inserm UMRS 592.
4:00 Z26 461.12 Astrogliosis characterzation throughout
acute and chronic demyelination in mice. N. E. HIBBITS*;
J. YOSHINO; R. PANNU; R. C. ARMSTRONG. USUHS,
Colgate Univ., USUHS.
1:00 Z27 461.13 Loss of mature oligodendrocytes
associated with vascular and cognitive impairment in
hypertensive white matter damage. F. Y. JALAL*; Y. YANG;
J. F. THOMPSON; A. C. LOPEZ; G. A. ROSENBERG. UNM.
2:00 Z28 461.14 NG2+ progenitor response in focal
white matter stroke: The origin and fate of oligodendrocyte
progenitors. E. G. SOZMEN*; S. T. CARMICHAEL. David
Geffen Sch. of Med. at UCLA.
3:00 Z29 461.15 Proteoglycan NG2 knock-out mice are
protected from EAE. G. FERRARA; S. MORANDO; F.
GIROLAMO; M. PRINCIPATO; M. ERREDE; S. CASAZZA;
D. VIRGINTINO; R. FURLAN; R. PERRIS; C. BENDOTTI*;
A. UCCELLI. Dept. Neuroscience, Mario Negri Insitute for
Pharmacol. Res., Dept. of Neurosciences, Ophthalmology
and Genetics, Univ. of Genoa, Dept. of Human Anat. and
Histology, Univ. Med. Sch., Neuroimmunology Unit, San
Raffaele Hosp., 5Centre for Mol. and Translational Oncology,
Univ. of Parma, Inst. Di Ricerche Farmacologiche.
Neuroscience 2011 | Monday PM | 113
Mon. PM